FrancophonIA/ELRC3.0 huggingface dataset:
English: In children less than 2 years, the lower glomerular function may protect against renal toxicity, but can lead to higher blood levels of cyclodextrins.
Maltese: Fit-tfal ta' inqas minn sentejn, il-funzjoni glomerulari baxxa tista' tipproteġi kontra t-tossiċità tal-kliewi, iżda tista' twassal għal livelli ogħla ta' cyclodextrins fid-demm.
English: Information to consider for the SmPC:
Maltese: Inkluzjoni ta' informazzjoni fil-SmPC:
English: May cause non-immunologic immediate contact reactions by a possible cholinergic mechanism.
Maltese: Jista' jikkawża reazzjonijiet ta' kuntatt immedjat mhux immunoloġiċi possibilment b' mekkaniżmu kolinerġiku.
English: 50 mg/kg/day Propylene glycol may cause skin irritation.
Maltese: 09/10/2017 Użu għall-ġilda 50 mg/kg/jum Propylene glycol jista' jikkawża irritazzjoniji filġilda.
English: Contains x g of a mixture of fructose and glucose per dose.
Maltese: Fih x g ta' taħlita ta' fructose u glukose f'kull doża.
English: Medical monitoring is required.
Maltese: Huwa meħtieġ monitoraġġ mediku.
English: 50 mg/kg/day If you are pregnant or breast‑feeding, do not take this medicine unless recommended by your doctor.
Maltese: 50 mg/kg/jum Jekk tbati minn mard tal-fwied jew tal-kliewi, tiħux din il-medicina sakemm ma tkunx rakkomandata mit-tabib tiegħek.
English: Macrogolglycerol ricinoleate (castor oil polyoxyl)
Maltese: Likwidu maltitol (Ġulepp tal-glukosju idroġinat)
English: Sodium laurilsulfate may cause local skin reactions (such as stinging or burning sensation) or increase skin reactions caused by other products when applied on the same area.
Maltese: Sodium laurilsulfate jista' jikkawża reazzjonijiet lokali tal-ġilda (bħal tingiż jew sensazzjoni ta' ħruq) jew iżid ir-reazzjonijiet tal-ġilda kkawżati minn prodotti oħra meta jiġu applikati fuq l-istess żona.
English: 10 g per dose May cause headache, stomach upset and diarrhea.
Maltese: 10 g f'kull doża Jista' jikkawża uġigħ ta' ras, dardir u dijarrea.
English: This medicine contains x mg alcohol (ethanol) in each <dosage unit><unit volume> <which is equivalent to x mg/<weight><volume>> (y% w/<w><v>).
Maltese: Din il-mediċina fiha x mg ta' alkoħol (ethanol) f'kull <unità ta' doża> <unità ta' volum> <li hija ekwivalenti għal x mg / <piż><volum>> <(y% w / <w><v>)>.
English: The minimum amount of benzyl alcohol at which toxicity may occur is not known.
Maltese: L-ammont minimu ta' benzyl alcohol li fih tista' sseħħ tossiċità mhuwiex magħruf.
English: Benzalkonium chloride 09/10/2017 Oromucosal, rectal and vaginal
Maltese: Benzalkonium chloride 09/10/2017 Użu għall-mukuza tal-halq, użu għal ġor-rektum u għal użu vaginali
English: Fragrances containing allergens*
Maltese: Fragranzi li fihom allerġeni*
English: In addition to allergic reactions in sensitised patients, nonsensitised patients may become sensitised.
Maltese: Minbarra r-reazzjonijiet allerġiċi f'pazjenti sensitizzati, pazjenti mhux sensittivi jistgħu jsiru sensitizzati.
English: Does not apply when bergapten is shown to be absent from the oil.
Maltese: Ma japplikax meta jkun jidher li bergapten mhux inkluż fiż-żejt.
English: In patients with moderate to severe renal dysfunction accumulation of cyclodextrins may occur.
Maltese: F'pazjenti b' indeboliment tal-kliewi moderat għal sever, lakkumulazzjoni ta' cyclodextrins tista' sseħħ.
English: This medicine contains x mg sodium laurilsulfate in each <dosage unit><unit volume> <which is equivalent to x mg/<weight><volume>>.
Maltese: Din il-mediċina fiha x mg sodium laurilsulfate f'kull <doża><volum> <li hu ekwivalenti għal x mg/<piż><volum>>.
English: SmPC proposal: Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
Maltese: Pazjenti li għandhom problemi ereditarji rari ta' intolleranza għall-fructose, malassorbiment tal-glucose-galactose jew nuqqas ta' sucrase-isomaltase, m'għandhomx jieħdu din il-mediċina.
English: Co-administration with any substrate for alcohol dehydrogenase such as ethanol may induce serious adverse effects in neonates.
Maltese: L-ammont żgħir ta' alkoħol f'din il-mediċina mhux se jkollu effetti notevoli.
English: The content of sorbitol in medicinal products for oral use may affect the bioavailability of other medicinal products for oral use administered concomitantly.
Maltese: Il-kontenut ta' sorbitol fi prodotti mediċinali għall-użu orali jista' jaffettwa l-bijodisponibilità ta' prodotti mediċinali oħra għall-użu orali mogħtija fl-istess ħin.
English: This medicine contains x mg benzalkonium chloride in each <dosage unit><unit volume> <which is equivalent to x mg/<weight><volume>>.
Maltese: Din il-mediċina fiha x mg ta' benzalkonium chloride f'kull <doża><volum> <li hu ekwivalenti għal x mg/<piż><volum>>.
English: EMA/206862/2016 EMEA/H/C/002280
Maltese: EMA/206862/2016 EMA/H/C/002280
English: The full EPAR for Giotrif can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Maltese: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Giotrif is available as tablets (20, 30, 40 and 50 mg) and is only available with a prescription.
Maltese: Giotrif jiġi bħala pilloli (20, 30, 40 u 50 mg) u huwa disponibbli biss b'riċetta ta' tabib.
English: The most common side effects with Giotrif (which may affect more than 1 in 10 people) are paronychia (nail bed infection), reduced appetite, epistaxis (nosebleeds), diarrhoea, nausea (feeling sick), vomiting, stomatitis (inflammation of the lining of the mouth), rash, acneiform dermatitis (acne-like skin conditions), pruritus (itching), and dry skin.
Maltese: L-effetti sekondarji l-aktar komuni b'Giotrif (li jistgħu jaffettwaw aktar minn persuna 1 minn kull 10) huma paronikija (infezzjoni fil-bażi tad-difer), tnaqqis fl-aptit, epistassi (fġir), dijarrea, nawżja (tħossok ma tiflaħx), remettar, stomatite (infjammazzjoni tal-kisja tal-ħalq), raxx, dermatite akneiforma (kondizzjonijiet tal-ġilda simili għall-akne), prurite (ħakk), u ġilda xotta.
English: The active substance in Giotrif, afatinib, is an ErbB family blocker.
Maltese: Is-sustanza attiva f'Giotrif, l-afatinib, hija imblokkatur tal-familja ErbB.
English: Other information about Giotrif
Maltese: Informazzjoni oħra dwar Giotrif
English: EGFR proteins are part of the ErbB family.
Maltese: Il-proteini EGFR huma parti mill-familja ErbB.
English: This is a summary of the European public assessment report (EPAR) for Giotrif.
Maltese: Dan huwa sommarju tar-rapport pubbliku Ewropew ta' valutazzjoni (EPAR) għal Giotrif.
English: Giotrif contains the active substance afatinib.
Maltese: Giotrif fih is-sustanza attiva afatinib.
English: In a second study in 795 patients with the squamous cell cancer type, patients treated with Giotrif lived on average for 2.6 months without their disease worsening compared with 1.9 months for patients treated with another cancer medicine, erlotinib.
Maltese: Fit-tieni studju, li fih ħadu sehem 795 pazjent bit-tip ta' kanċer taċ-ċelloli skwamużi, il-pazjenti li rċevew kura b'Giotrif għexu medja ta' 2.6 xhur mingħajr ma l-marda tagħhom aggravat meta mqabbla ma' 1.9 xhur għal pazjenti li rċevew kura b'mediċina oħra kontra l-kanċer, erlotinib.
English: Why is Giotrif approved?
Maltese: Għaliex ġie approvat Giotrif?
English: The European Commission granted a marketing authorisation valid throughout the European Union for Giotrif on 25 September 2013.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida fl-Unjoni Ewropea kollha għal Giotrif fil-25 ta' Settembru 2013.
English: In a main study in 345 patients with tumours that have mutated EGFR genes, patients treated with Giotrif lived on average for 11 months without their disease getting worse compared with 7 months for patients who were treated with two other cancer medicines, pemetrexed and cisplatin.
Maltese: Fi studju ewlieni wieħed, li fih ħadu sehem 345 pazjent b'tumuri b'ġeni mutati għal EGFR, il-pazjenti li rċevew kura b'Giotrif għexu medja ta' 11-il xahar mingħajr ma l-marda tagħhom aggravat meta mqabbla ma' 7 xhur għal pazjenti li rċevew kura b'żewġ mediċini oħra kontra l-kanċer, pemetrexed u cisplatin.
English: Lung cancer cells with mutated EGFR proteins are particularly sensitive to afatinib.
Maltese: Iċ-ċelloli tal-kanċer tal-pulmun bi proteini mutati għal EGFR huma partikolarment sensittivi għall-afatinib.
English: The recommended dose is 40 mg once daily but this may be increased to up to 50 mg per day in patients who tolerate the 40 mg dose, or interrupted and reduced in patients experiencing side effects.
Maltese: Id-doża rakkomandata hija ta' 40 mg darba kuljum iżda din tista' tiżdied sa 50 mg kuljum f'pazjenti li jittolleraw id-doża ta' 40 mg, jew tiġi interrotta u mnaqqsa f'pazjenti li jesperjenzaw effetti sekondarji.
English: • when the cancer has a mutation in the gene for a protein called EGFR and has not been previously treated with tyrosine kinase inhibitor medicines.
Maltese: • meta l-kanċer ikollu mutazzjoni fil-ġene għal proteina msejħa EGFR u li ma kienx ikkurat qabel b'mediċini inibituri tat-tirożina kinażi.
English: What are the risks associated with Giotrif?
Maltese: X'inhuma r-riskji assoċjati ma' Giotrif?
English: • when the cancer is of a squamous cell type (from cells of the lining of the lungs) and has worsened despite treatment with platinum-based chemotherapy.
Maltese: • meta l-kanċer ikun ta' tip ta' ċelloli skwamużi (minn ċelloli tal-kisja tal-pulmuni) u li aggrava minkejja l-kura b'kimoterapija bbażata fuq il-platinu.
English: In addition, the side effects of the medicine were considered to be manageable and similar to those seen with medicines of the same class.
Maltese: Barra minn hekk, l-effetti sekondarji tal-mediċina kienu meqjusa maniġġabbli u simili għal dawk li dehru b'mediċini tal-istess klassi.
English: A risk management plan has been developed to ensure that Giotrif is used as safely as possible.
Maltese: Ġie żviluppat pjan tal-ġestjoni tar-riskju biex jiġi żgurat li Giotrif jintuża bl-aktar mod sigur possibbli.
English: Treatment with Giotrif should be started and supervised by a doctor experienced in the use of cancer medicines.
Maltese: Il-kura b'Giotrif għandha tinbeda u tkun taħt is-superviżjoni ta' tabib b'esperjenza fl-użu ta' mediċini kontra l-kanċer.
English: For the full list of all side effects and restrictions with Giotrif, see the package leaflet.
Maltese: Għal-lista sħiħa tal-effetti sekondarji kollha rrapportati b'Giotrif, ara l-fuljett ta' tagħrif.
English: By blocking these proteins, afatinib helps to control cell division and thereby slows down the growth and spread of the non-small cell lung cancer.
Maltese: Billi timblokka dawn il-proteini, l-afatinib tgħin tikkontrolla l-qsim taċ-ċelloli u b'hekk tnaqqas it-tkabbir u l-firxa tal-kanċer tal-pulmun taċ-ċelloli mhux żgħar.
English: The CHMP considered that in patients treated with Giotrif the improvement in progression-free survival (how long they lived without the disease getting worse) was a meaningful benefit for patients.
Maltese: Is-CHMP ikkunsidra li f'pazjenti li kienu qed jirċievu kura b'Giotrif it-titjib fis-sopravivenza ħielsa mill-progressjoni (it-tul ta' żmien li għexu mingħajr ma l-marda aggravat) kien ta' benefiċċju sinifikanti għall-pazjenti.
English: What measures are being taken to ensure the safe and effective use of Giotrif?
Maltese: X'miżuri qegħdin jittieħdu biex jiġi żgurat l-użu sigur u effettiv ta' Giotrif?
English: This means that it blocks the action of a group of proteins known as ‘ErbB family' which are found on the surface of cancer cells and are involved in stimulating the cells to divide.
Maltese: Dan ifisser li timblokka l-azzjoni ta' grupp ta' proteini magħrufa bħala l-‘familja ErbB' li jinsabu fuq il-wiċċ taċ-ċelloli tal-kanċer u huma involuti fl-istimulazzjoni taċ-ċelloli biex jinqasmu.
English: It is not intended to provide practical advice on how to use Giotrif.
Maltese: Dan mhux intiż biex jipprovdi konsultazzjoni prattika dwar l-użu ta' Giotrif.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that the benefits of Giotrif outweigh its risks and recommended that it be granted marketing authorisation in the EU.
Maltese: Il-Kumitat għall-Prodotti Mediċinali għall-Użu mill-Bniedem (CHMP) tal-Aġenzija ddeċieda li l-benefiċċji ta' Giotrif huma akbar mir-riskji tiegħu u rrakkomanda li jingħata awtorizzazzjoni għat-tqegħid fis-suq fl-UE.
English: How does Giotrif work?
Maltese: Kif jaħdem Giotrif?
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Giotrif, including the appropriate precautions to be followed by healthcare professionals and patients.
Maltese: Abbażi ta' dan il-pjan, fis-sommarju tal-karatteristiċi tal-prodott u l-fuljett ta' tagħrif ġiet inkluża informazzjoni rigward is-sigurtà ta' Giotrif, inklużi l-prekawzjonijiet xierqa li għandhom ikunu segwiti mill-professjonisti tal-kura tas-saħħa u mill-pazjenti.
English: EMA/CVMP/19896/2007 EMEA/V/C/000082
Maltese: EMA/628208/2012 EMEA/V/C/000082
English: The product was shown to be comparable to other reference products (carprofen and meloxicam, respectively).
Maltese: Il-prodott intwera li kien komparabbli ma' prodotti oħra ta' referenza (carprofen u meloxicam, rispettivament).
English: Firocoxib blocks the enzyme (cyclo-oxygenase) that is involved in the production of prostaglandins.
Maltese: Firocoxib jimblokka l-enzima (cyclo-oxygenase) involuta fil-produzzjoni ta' prostaglandini.
English: Previcox is presented as chewable tablets for dogs (57 mg and 227 mg) and as an oral paste for horses (8.2 mg/g).
Maltese: Previcox huwa ppreżentat bħala pilloli li jintmagħdu għall-klieb (57 mg u 227 mg) u bħala pejst orali għaż-żwiemel (8.2 mg/g).
English: Horse:
Maltese: Żwiemel:
English: Previcox contains firocoxib, which belongs to a class of medicines called non-steroidal antiinflammatory drugs (NSAIDs) belonging to the Coxib group, which acts by selective inhibition of cyclooxygenase-2 (COX-2).
Maltese: Previcox fih firocoxib, li jagħmel parti minn klassi ta' mediċini msejħa mediċini anti-infjammatorji mhux sterojdi (NSAIDs) li jagħmlu parti mill-grupp Coxib, li jaħdmu permezz ta' inibizzjoni selettiva ta' cyclooxygenase-2 (COX-2).
English: Why has Previcox been approved?
Maltese: Għalxiex ġie approvat Previcox?
English: The European Commission granted a marketing authorisation valid throughout the European Union for Previcox on 13 September 2004.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida madwar l-Unjoni Ewropea għal Previcox fit-13 ta' Settembru 2004.
English: What is the risk associated with Previcox?
Maltese: X'riskji huma assoċjati ma' Previcox?
English: What is Previcox?
Maltese: X'inhu Previcox?
English: Coxibs display pain relief, anti-inflammatory and antipyretic properties.
Maltese: Coxibs juru karatteristiċi ta' serħan mill-uġigħ, anti-infjammatorji u antipiretiċi.
English: Previcox contains the active substance firocoxib, which belongs to a class of medicines having antiinflammatory action.
Maltese: Previcox fih is-sustanza attiva firocoxib, li tagħmel parti minn klassi ta' mediċini b'azzjoni antiinfjammatorja.
English: How has Previcox been studied?
Maltese: Kif ġie studjat Previcox?
English: The CVMP concluded that Previcox oral paste was as effective as other authorised products (phenylbutazone and vedaprofen) in the alleviation of pain and inflammation associated with osteoarthritis and the reduction of associated lameness in horses.
Maltese: Is-CVMP ikkonkluda li Previcox pejst orali kien effettiv daqs prodotti oħra awtorizzati (phenylbutazone u vedaprofen) fit-taffija ta' uġigħ u ta' infjammazzjoni assoċjati ma' osteoartrite u fit-tnaqqis ta' zappzip assoċjat fiż-żwiemel.
English: The side effects of Previcox are typical for those seen with other medicines in this product class (NSAIDs) such as oral lesions (tissue damage) in the mouth of horses, soft faeces/diarrhoea or lethargy.
Maltese: L-effetti sekondarji ta' Previcox huma tipiċi għal dawk li dehru b'mediċini oħra f'din il-klassi ta' prodotti (NSAIDs) bħal feriti orali (ħsara fit-tessut) fil-ħalq taż-żwiemel, ippurgar artab/dijarea jew letarġija.
English: If you want more information on the basis of the CVMP recommendations, read the Scientific Discussion (also part of the EPAR).
Maltese: Jekk tixtieq iktar informazzjoni relatata marrakkomandazzjonijiet tas-CVMP, aqra d-Diskussjoni Xjentifika (parti wkoll mill-EPAR).
English: Previcox oral paste administered once daily for 14 days at a dose of 0.1 mg/kg improved clinical scores for lameness and soft tissue injuries in horses and also helped alleviate pain and inflammation associated with osteoarthritis in horses.
Maltese: Previcox pejst orali mogħti darba kuljum għal 14-il ġurnata f'doża ta' 0.1 mg/kg tejjeb il-punteġġ kliniku għal zapzip u għal ħsara lit-tessut artab fiż-żwiemel u wkoll għen itaffi l-uġigħ u infjammazzjoni assoċjati ma' osteoartrite fiż-żwiemel.
English: This summary was last updated in April 2012.
Maltese: Dan is-sommarju ġie aġġornat l-aħħar f'April 2012.
English: Previcox has been studied in laboratory animals, as well as in dogs and horses that were treated in various veterinary practices/clinics across Europe (“clinical studies”).
Maltese: Previcox ġie studjat fuq annimali f'laboratorju, kif ukoll fuq klieb u żwiemel li kienu kkurati f'bosta prattiċi/kliniċi veterinarji madwar l-Ewropa (“studji kliniċi”).
English: Two multi-centre studies were conducted (one in the US and one in Europe) to investigate the efficacy, safety and acceptability of firocoxib under field conditions when administered to horses orally once daily for 14 days at a dose of 0.1 mg/kg.
Maltese: Saru żewġ studji multiċentriċi (wieħed fl-Istati Uniti u wieħed fl-Ewropa) biex jinvestigaw l-effikaċja, is-sigurtà u l-aċċettabilità ta' firocoxib taħt kundizzjonijiet fuq il-post meta jingħata liż-żwiemel b'mod orali darba kuljum għal 14-il ġurnata f'doża ta' 0.1 mg/kg.
English: Other information about Previcox:
Maltese: Tagħrif ieħor dwar Previcox:
English: What benefit has Previcox shown during the studies?
Maltese: Liema benefiċċju wera Previcox waqt l-istudji li twettqu?
English: The Committee for Medicinal Products for Veterinary Use (CVMP) decided that the benefits of Previcox are greater than any risks of treatment and they recommended that Previcox should be given a marketing authorisation.
Maltese: Il-Kumitat għall-Prodotti Mediċinali għall-Użu Veterinarju (CVMP) iddeċieda li l-benefiċċji ta' Previcox huma akbar minn kwalunkwe riskju ta' kura u rrakkomanda li Previcox għandu jingħata awtorizzazzjoni għat-tqegħid fis-suq.
English: How does Previcox work?
Maltese: Għal xiex jintuża Previcox?
English: Previcox is used for a relief of pain and inflammation associated with osteoarthritis, soft-tissue, orthopaedic and dental surgery in dogs and for the alleviation of pain and inflammation associated with osteoarthritis and reduction of associated lameness in horses.
Maltese: Previcox jintuża għas-serħan mill-uġigħ u għal infjammazzjoni assoċjati ma' osteoartrite, mat-tessut artab, ma' kirurġija ortopedika u dentali fil-klieb u għat-taffija mill-uġigħ u għal infjammazzjoni assoċjati ma' osteoartrite u għat-tnaqqis ta' zapzip assoċjat fiż-żwiemel.
English: Information on the prescription status of this product may be found on the label of the carton.
Maltese: Informazzjoni dwar l-istat tal-preskrizzjoni ta' dan ilprodott tista' tinstab fuq it-tikketta tal-kartuna.
English: 1123 Budapest Hungary
Maltese: 1123 Budapest
English: in the last years: bovine: 45 to 86%; porcine: 4% to 27%.
Maltese: Fl-aħħar snin: bovini: 45% sa 86%; majjali: 4% sa 27%.
English: 21 Montee De La Garde 69340 Francheville France
Maltese: 21 Montee De La Garde 69340 Francheville Franza
English: Burgos Spain
Maltese: Burgos Spanja
English: Friulchem via San Marco, 23 33099 Vivaro (PN) Italy
Maltese: Friulchem via San Marco, 23 33099 Vivaro (PN)
English: and Proteus spp.
Maltese: u Proteus spp.
English: Belgium Vandenbussche Farma Service Brusselsesteenweg 396
Maltese: Il-Belġju Vandenbussche Farma Service Brusselsesteenweg 396
English: Bayer Hungária Kft. Alkotás u. 50.
Maltese: L-Ungerija Bayer Hungária Kft. Alkotás u. 50.
English: 20037 Paderno Dugnano (MI) Italy
Maltese: 20037 Paderno Dugnano (MI) L-Italja
English: 8501 Novo Mesto Slovenia
Maltese: 8501 Novo Mesto Is-Slovenja
English: Novo mesto Smarjeska cesta 6 8501 Novo Mesto Slovenia
Maltese: Novo mesto Smarjeska cesta 6 8501 Novo Mesto Is-Slovenja
English: Romikim Farma SL Gran Via Carlos III, 98,6 8027 Barcelona Spain
Maltese: Romikim Farma SL Gran Via Carlos III, 98,6 8027 Barcelona Spanja
English: Drwalewskie Zakłady Przemysłu Bioweterynaryjnego S.A.
Maltese: Il-Polonja Drwalewskie Zakłady Przemysłu Bioweterynaryjnego S.A.
English: 949 01, Nitra Slovakia
Maltese: 949 01, Nitra
English: Dto 2775-696 Carcavelos Portugal
Maltese: Dto 2775-696 Carcavelos
English: LABORATORIOS VELVIAN S.L C/Vitoria 9, 2 B
Maltese: Ir-Rumanija LABORATORIOS VELVIAN S.L C/Vitoria 9, 2 B
English: 05-651 Drwalew Poland
Maltese: 05-651 Drwalew
English: Rev Sci Tech Off Int Epiz 2009;28:1119-1128
Maltese: Rev Sci Tech Off Int Epiz 2009;28:1119-1128 5 Agnoletti et al.
English: 48308 Senden-Bösensell Germany
Maltese: 48308 Senden-Bösensell Il-Ġermanja
English: Bayer SpA Viale Certosa, 130 20156 Milano Italy
Maltese: Bayer SpA Viale Certosa, 130 20156 Milano L-Italja
English: Agnoletti et al. First reporting of methicillin-resistant Staphylococcus aureus (MRSA) ST398 in an industrial rabbit holding and in farm-related people.
Maltese: First reporting of methicillin-resistant Staphylococcus aureus (MRSA) ST398 in an industrial rabbit holding and in farm-related people.
English: Przedsiębiorstwo Wielobranżowe VET-AGRO Sp. z o.o.
Maltese: Il-Polonja Przedsiębiorstwo Wielobranżowe VET-AGRO Sp. z o.o.
English: Bayer PORTUGAL S.A. Rua Quinta do Pinheiro, 5 2794-003 Carnaxide Portugal
Maltese: Bayer IL-PORTUGALL S.A. Rua Quinta do Pinheiro, 5 2794-003 Carnaxide Il-Portugall
English: Cattle, pig
Maltese: Frat, pig
English: D-88326 Aulendorf Germany
Maltese: D-88326 Aulendorf Il-Ġermanja
English: aureus, together with a bacteriological cure of 66.67%.
Maltese: Staph. aureus, flimkien ma' kura batterjoloġika ta' 66,67%.
English: Germany Calluna Pharma bvba Treslong 34
Maltese: Il-Ġermanja Calluna Pharma bvba Treslong 34
English: Litvínovská 609/3 190 21 Praha 9
Maltese: 190 21 Praha 9
English: and Actinobacillus pleuropneumoniae.
Maltese: U Actinobacillus pleuropneumoniae.
English: Via G. Puecher, 8
Maltese: Puecher, 8
English: 8 CVMP note for guidance on the approach towards harmonisation of withdrawal periods (EMEA/CVMP/036/95)http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004428.pdf
Maltese: 8 CVMP note for guidance on the approach towards harmonisation of withdrawal periods (EMEA/CVMP/036/95)http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004428.pdf irriżulta f'perjodu ta' tiżmim ta' 12-il jum.
English: Drugs Italia s.r.l.
Maltese: Italia s.r.l.
English: Animal Health Division Bayer House Strawberry Hill Newbury
Maltese: Ir-Renju Unit Bayer plc Animal Health Division Bayer House Strawberry Hill Newbury
English: ESTEVE FARMA, LDA Av. Do Forte, 3
Maltese: ESTEVE FARMA, LDA Av.
English: B-2321 Hoogstraten Belgium
Maltese: B-2321 Hoogstraten Il-Belġju
English: The clinical response rate was 92%.
Maltese: Ir-rata ta' reazzjoni klinika kienet 92%.
English: B-2322 Hoogstraaten Belgium
Maltese: B-2322 Hoogstraaten Il-Belġju
English: Repeated injections should be made at different injection sites.
Maltese: Għandhom isiru injezzjonijiet ripetuti f'siti ta' injezzjoni differenti.
English: Cattle, pigs >25kg
Maltese: Frat, majjali >25kg
English: S.C. ROMVAC COMPANY S.A. Şos.
Maltese: ROMVAC COMPANY S.A. Şos. Centurii, nr. 7
English: Bayer Limited The Atruim Blackthorn Road Dublin 18
Maltese: Blackthorn Road Dublin 18
English: The presence of bacteria including E. coli was determined.
Maltese: Ġiet iddeterminata lpreżenza ta' batterji inkluż E. coli.